4basebio PLC
4BB
Rank in Stocks
#19302
4basebio PLC, an enterprise established in 2020 and situated in Cambridge,... 4basebio PLC, an enterprise established in 2020 and situated in Cambridge, United Kingdom, is dedicated to the entire process, from conception to delivery, of synthetic DNA and RNA products. The company also provides advanced non-viral vector solutions, with operations spanning the United States, Europe, and other international markets. Their comprehensive offerings encompass research kits, bulk enzymes, various other biological products, as well as crucial licensing and AVV manufacturing services. The company primarily caters to clients within the biotech, pharmaceutical, and contract development and manufacturing organization (CDMO) industries. Notably, the firm adopted its current name, 4basebio PLC, in July 2021, having previously been known as 4basebio UK Societas.
Share Price
$7.06
Last synced: 2026-11-10
Market Cap
$109.65M
Change (1 day)
0.00%
Change (1 year)
-25.48%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade 4basebio PLC (4BB)
Category
Healthcare
Operating Margin for 4basebio PLC (4BB)
Operating Margin as of November 2026 TTM: -2,232.91%
According to 4basebio PLC's latest financial reports, its current operating margin (TTM) is -2,232.91%. At the end of 2025 the company had an operating margin of -988.01%.
Operating Margin history for 4basebio PLC from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -2,232.91% | 126.00% |
| 2025 | -988.01% | -23.45% |
| 2024 | -1,290.68% | -18.89% |
| 2023 | -1,591.30% | -26.97% |
| 2022 | -2,179.10% | 108.83% |
| 2021 | -1,043.49% | 675.08% |
| 2020 | -134.63% | -35.25% |
| 2019 | -207.92% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.02% |
US
|
|
| -149.01% | -99.93% |
US
|
|
| 25.57% | -100.01% |
AU
|
|
| 31.23% | -100.01% |
BE
|
|
| 29.35% | -100.01% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about 4basebio PLC's operating margin
What is 4basebio PLC's operating margin?
4basebio PLC's operating margin is -2,232.91%, as of Nov 2026.
What was 4basebio PLC's operating margin in 2025?
In 2025, 4basebio PLC's operating margin was -988.01%, compared with -1,290.68% in 2024.
How has 4basebio PLC's operating margin changed since 2020?
From 2020 to 2025, 4basebio PLC's operating margin was highest in 2020 (-134.63%) and lowest in 2022 (-2,179.10%).
How does 4basebio PLC's operating margin compare with similar companies?
4basebio PLC's operating margin (-2,232.91%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.